Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-Current Debt
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Depreciation & Amortization (CF): 2020-2025

Historic Depreciation & Amortization (CF) for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $5.0 million.

  • CureVac N.V's Depreciation & Amortization (CF) fell 9.61% to $5.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $19.4 million, marking a year-over-year decrease of 18.26%. This contributed to the annual value of $20.1 million for FY2024, which is 20.12% down from last year.
  • Latest data reveals that CureVac N.V reported Depreciation & Amortization (CF) of $5.0 million as of Q2 2025, which was up 3.64% from $4.8 million recorded in Q1 2025.
  • Over the past 5 years, CureVac N.V's Depreciation & Amortization (CF) peaked at $10.2 billion during Q1 2022, and registered a low of -$13.0 billion during Q4 2021.
  • For the 3-year period, CureVac N.V's Depreciation & Amortization (CF) averaged around $5.5 million, with its median value being $5.4 million (2024).
  • Per our database at Business Quant, CureVac N.V's Depreciation & Amortization (CF) slumped by 317,208.72% in 2021 and then surged by 261,943.42% in 2022.
  • Quarterly analysis of 5 years shows CureVac N.V's Depreciation & Amortization (CF) stood at -$13.0 billion in 2021, then skyrocketed by 100.00% to $399,937 in 2022, then skyrocketed by 1,510.67% to $6.4 million in 2023, then decreased by 28.60% to $4.6 million in 2024, then decreased by 9.61% to $5.0 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $5.0 million for Q2 2025, versus $4.8 million for Q1 2025 and $4.6 million for Q4 2024.